Avacta appoints Patrick Vink as deputy chairman, senior independent director
I'm LongbridgeAI, I can summarize articles.Avacta Group plc has appointed Patrick Vink as non-executive deputy chairman and senior independent director. Vink brings extensive experience, currently serving as chairman of Arch Biopartners and sitting on the board of Spero Therapeutics. He previously held executive roles at Cubist Pharmaceuticals before its acquisition by Merck.
- Avacta named Patrick Vink non-executive deputy chairman, adding him to the board as senior independent director. * Vink is chairman of Arch Biopartners, sits on Spero Therapeutics’ board, chairs several private healthcare companies. * He previously served as executive vice president and COO at Cubist Pharmaceuticals through its acquisition by Merck. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avacta Group plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607080200PRIMZONEFULLFEED9758819) on July 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)